Quidel

News Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Date Title
12/17/14Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program
12/10/14Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Bordetella Pertussis
12/02/14Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering
12/01/14Quidel Announces Proposed Offering of $150 Million of Convertible Senior Notes
11/18/14Dr. Kenneth J. Widder Joins Quidel's Board of Directors
10/21/14Quidel Reports Third Quarter 2014 Financial Results
10/15/14Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3
10/13/14Quidel Receives FDA Clearance for Its Lyra(R) Molecular PCR Assay for the Detection of Adenovirus
10/06/14Quidel to Hold Third Quarter 2014 Financial Results Conference Call on October 21, 2014
08/22/14Quidel to Present at Baird 2014 Health Care Conference
07/28/14Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
07/22/14Quidel Reports Second Quarter 2014 Financial Results
07/08/14Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014
06/04/14Quidel to Present at Wells Fargo Securities 2014 Healthcare Conference
06/02/14Quidel Receives CLIA Waiver for Its Sofia(R) Diagnostic Test for Respiratory Syncytial Virus (RSV)
05/14/14Quidel Receives FDA Clearance for Its Molecular PCR Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus
04/29/14Quidel to Present at Bank of America Merrill Lynch 2014 Health Care Conference
04/23/14Quidel Reports First Quarter 2014 Financial Results
04/22/14Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G
04/15/14Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014
03/27/14Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2
02/18/14Quidel to Present at Cowen 34th Annual Health Care Conference
02/11/14Quidel Reports Fourth Quarter and Full Year 2013 Financial Results
01/28/14Quidel to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on February 11, 2014
01/08/14Quidel Announces Preliminary Revenue for Fourth Quarter 2013